CSS LLC’s NKGen Biotech NKGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-52,753
Closed -$525K – 936
2022
Q4
$525K Sell
52,753
-106,349
-67% -$1.05M 0.03% 371
2022
Q3
$1.55M Sell
159,102
-131,948
-45% -$1.29M 0.07% 264
2022
Q2
$2.83M Buy
291,050
+523
+0.2% +$5.09K 0.12% 213
2022
Q1
$2.82M Buy
290,527
+189,424
+187% +$1.84M 0.1% 202
2021
Q4
$980K Buy
+101,103
New +$984K 0.03% 437

Other funds holding NKGN

CSS LLC's NKGN Position: Q1 2023 in Review

CSS LLC sold out of NKGen Biotech (NKGN) in Q1 2023, closing a stake of 52,753 shares — an estimated $525K sold.

CSS LLC first reported a position in NKGN in Q4 2021 and held it in 5 quarters. The position peaked at $2.83M in Q2 2022. 55 funds tracked by Wall St. Rank hold NKGN as of Q1 2023.

  • CSS LLC reported no remaining NKGen Biotech position as of Q1 2023 after selling out during the quarter.
  • CSS LLC sold 52,753 NKGen Biotech shares in Q1 2023, an estimated $525K.
  • CSS LLC first reported a position in NKGen Biotech in Q4 2021 and held it in 5 quarters.
  • CSS LLC's NKGen Biotech position peaked at $2.83M in Q2 2022.
  • 55 funds tracked by Wall St. Rank held NKGen Biotech as of Q1 2023.

Based on CSS LLC's 13F filing for Q1 2023, filed 15 May 2023.